Description: Anteo Diagnostics Limited is a nano-technology company. The Company is engaged in the development and commercialization of specialized surfaces used in life sciences, and the research and development of surfaces for specific binding of proteins (abiotics). It is engaged in offering products for sale into in-vitro diagnostics, point of care, medical devices and bioseparations markets. Its segments include Australia and Belgium. The Company offers nanoglue technology, called Mix&Go for healthcare markets. It also develops, manufactures and distributes products for the life sciences, clinical diagnostics and bio-separations markets and is creating new applications in the energy and medical devices sectors. It provides functional nanometer-thin coatings and binders across a range of industries and applications. Its subsidiaries include Anteo Technologies Pty Limited, Anteo Energy Pty. Limited, Aged Care Diagnostics Pty Limited, DIAsource Immunoassays SA and DIAsource IBERIA SL.
Home Page: www.anteotech.com
ADO Technical Analysis
Northern Lights Fund Trust III
,
Phone:
61 7 3219 0085
Officers
| Name | Title |
|---|---|
| Mr. Timothy J. Pritchard B.Bus, CPA, GIA (Cert), MCom, MIT | CFO & Company Sec. |
| Mr. Christopher Parker | Chair of the Clinical Advisory Board & Non Exec. Director |
| Mr. David John Radford BSc (Hons), MAICD, MBA | MD, CEO & Director |
| Dr. N. Joe Maeji B.Sc., Ph.D. | Founder & Chief Scientific Officer |
| Ms. Katrina Byrne | Chief Operating Officer |
| Ms. Friederike Graser | Communications Mang. |
| Dr. Charlie Huang B.Sc., Ph.D. | Chief Innovation Officer |
| Mr. Selahattin Guldu | Exec. VP of Commercial Banking |
| Mr. Manuel Wieser | Head of Energy |
| Mr. Pierre Nathie | Head of Products & Services ? Life Sciences |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.9758 |
| Price-to-Sales TTM: | 154.1502 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |